Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin Palmitate Hydrochloride Dispersible Tablet for Bacterial Vaginosis
NCT03080740Phase 4Unknown
- Sponsor
- ApicHope Pharmaceutical Group
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clindamycin in bacterial vaginosis (BV) (2 arms), sponsored by ApicHope Pharmaceutical Group. Primary endpoint: Nugent score. Status: unknown.
02
Drugs
clindamycin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03080740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080740.